Noopept in the treatment of mild cognitive impairment in patients with stroke

The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Search result: 0

Amelin A.V.

Sankt-Peterburg

Iliukhina A.Iu.

Shmonin A.A.

First Saint-Petersburg Pavlov State Medical University, Saint-Petersburg;
The Northwestern Federal Medical Research Center, Saint-Petersburg;
Saint-Petersburg City Hospital №26, 196247, Saint-Petersburg, Russia

Noopept in the treatment of mild cognitive impairment in patients with stroke

Authors:

Amelin A.V., Iliukhina A.Iu., Shmonin A.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(10): 44‑46

Read: 9112 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Amelin AV, Iliukhina AIu, Shmonin AA. Noopept in the treatment of mild cognitive impairment in patients with stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(10):44‑46. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

Abstract:

Noopept is a neuroprotector and nootropics. Literature data revealed the treatment effect of noopept on mild cognitive impairment in patients with discirculatory encephalopathy. The present open prospective study included 60 patients with stroke treated with noopept during 12 months. Cognitive functions were assessed before and after treatment using neuropsychological tests. An analysis of MMSE scores and lateral and categorical associations revealed the significant improvement of cognitive functions after 2 months in patients of the main group compared to the controls. The global assessment of efficacy revealed the mild improvement in the main group while no changes were found in the control group. The results have demonstrated that noopept, used in dose 20mg daily during 2 months, improves cognitive functions in stroke patients and has a high level of safety.

Keywords:

noopept

ischemic stroke

mild cognitive impairment in patients with stroke

Authors:

Amelin A.V.

Sankt-Peterburg

Iliukhina A.Iu.

Shmonin A.A.

First Saint-Petersburg Pavlov State Medical University, Saint-Petersburg;
The Northwestern Federal Medical Research Center, Saint-Petersburg;
Saint-Petersburg City Hospital №26, 196247, Saint-Petersburg, Russia

Close metadata

References:

Avedisova A.S., Yastrebov D.V. Sravnitel'naya effektivnost' noopepta i piratsetama pri terapii astenicheskikh rasstroistv i narushenii organicheskogo geneza. Rus med zhurn 2007; 5: 434-437.
Zakharov V.V., Yakhno N.N. Narusheniya pamyati. M: GeotarMed 2003; 150.
Neznamov G.G., Teleshova E.S. Rezul'taty sravnitel'nogo izucheniya noopepta i piratsetama pri lechenii bol'nykh s legkimi kognitivnymi narusheniyami pri organicheskikh zabolevaniyakh golovnogo mozga sosudistogo i travmaticheskogo geneza. Zhurn nevrol i psikhiat 2008; 108: 3: 33-42.
Testy, shkaly oprosniki. V pomoshch' praktikuyushchemu vrachu. M 2006.
Yakhno N.N., Zakharov V.V. Sosudistye kognitivnye rasstroistva. Rus med zhurn 2005; 13: 12: 789-793.
Yakhno N.N. Kognitivnye rasstroistva v nevrologicheskoi praktike. Nevrol zhurn 2006; Prilozhenie 1: 4-12.
Yakhno N.N., Suslina Z.A., Gribacheva I.A. i dr. Vliyanie preparata bilobil forte na umerennye kognitivnye narusheniya u patsientov s distsirkulyatornoi entsefalopatiei I-II stadii: kliniko-neiropsikhologicheskoe issledovanie. Rus med zhurn 2008; 16: 12: 1626-1629.
Cerebrovascular disease, cognitive impairment and dementia. Second edition of Cerebrovascular disease and dementia. Edited by J. O'Brien, D. Ames, L. Gustafson et al. Martin Dunitz 2004.
DiCarlo A., Baldereschi M., Amaducci L. et al. Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J Am Ger Soc 2000; 48: 775-782.
ECDEU Assessment Manual for Psychopharmacology. Edited by W. Guy. 1976. Rockville, MD, U.S. Department of Health, Education, and Welfare.
Graham J.E., Rockwood K., Beattie E.L. et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349: 1793-1796.
Hachinski V., Bowler J.V. Vascular dementia: diagnostic criteria for research studies. Neurology 1993; 43: 2159-2160.
Lovenstone S., Gauthier S. Management of dementia. London: Martin Dunitz 2001.
Rockwood K., Wentzel C, Hachinski V. et al. Prevalence and outcomes of vascular cognitive impairment. Neurology 2000; 54: 447-451.
Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiat Scand 1983; 67: 6: 361-370.

Log in to the site using your account in one of the services

Registration

Last Name

Name

Middle Name

E-mail

Phone

Address

Country

Zip

City

Region

Street

Home

Apartmen

Legal entity name

ИНН

КПП

Password

Password

Repeat password

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.